logo

Sonoma Pharmaceuticals Inc.’s Banking’s 100-Day Moving Average at 0.1651: Will the Stock Break Through?

VIPS stock

The market performance of Sonoma Pharmaceuticals Inc. has been somewhat unstable. Over the past year, the company’s stock achieved a high of $1.52 on 06/09/23, with the lowest value for the same timeframe being $0.12, recorded on 11/10/23.

52-week price history of SNOA Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Sonoma Pharmaceuticals Inc.’s current trading price is -88.45% away from its 52-week high, while its distance from the 52-week low is 51.42%. The stock’s price range during this period has fluctuated between $0.12 and $1.52. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.78 million for the day, which was evidently lower than the average daily volume of 1.6 million over the last three months.

Financial Performance and Market Capitalization

Sonoma Pharmaceuticals Inc. (SNOA) has experienced a quarterly decline of -24.22% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.74M and boasts a workforce of 171 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.1651, with a change in price of +0.0189. Similarly, Sonoma Pharmaceuticals Inc. recorded 1,817,395 in trading volume during the last 100 days, posting a change of +12.07%.

SNOA Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SNOA stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.02.

SNOA Stock Stochastic Average

Sonoma Pharmaceuticals Inc.’s raw stochastic average for the past 50 days is currently at 73.03%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 73.03%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 67.16% and 56.27%, respectively.

SNOA Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -2.72%.However, over the last six months, we can see a stronger performance of -75.09%. Over the last 30 days, the price of SNOA has fallen by 28.10%. And in the last five days, it has surged by 15.23%.